SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Jensen Huangs acknowledged affair with a businesswoman reportedly suspected of ties to Chinese intelligence, and Nvidias board investigation into related concerns, are weighing on shares. Traders disagree on whether the episode threatens leadership and investor confidence or is an overreaction with little impact on Nvidias AI-chip business; dip-buying and bearish calls are both prominent.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQs stronger-than-expected Q3 results and raised full-year revenue outlook are driving attention, with traders also pointing to record backlog and demand for its quantum systems. Bulls welcome the growth and commercial momentum, while skeptics question cash burn, acquisition-driven revenue, and dilution.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims Q3 earnings are in focus after a sharp selloff, with traders weighing the impact of its Eli Lilly deal to offer branded obesity drugs on the platform. Bulls see expanded GLP-1 access as a growth opportunity, while skeptics worry the shift from compounded products could pressure margins; claims of leaked results remain speculation.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candels positive Phase 3 prostate cancer results and planned CAN-2409 BLA filing are the main focus, with recent SITC immune-profiling and viral-shedding data drawing added attention to the program. Bulls see the data and filing as potential catalysts, while skeptics question the timeline, financing needs and managements transparency.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. The firm operates through the following geographical segments: United States and International. It offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Trade Desk shares are surging ahead of its Q3 earnings report, with traders attributing the move to short covering and speculating about a possible earnings leak, though no leak is confirmed. The rally is contentious: some expect a turnaround or squeeze, while others fear the report and outlook will disappoint after weakening growth.

Take-Two Interactive Software, Inc. engages in the development, publishing, and marketing of interactive software games. Its products are designed for console systems, handheld gaming systems, and personal computers, including smart phones and tablets, and are delivered through physical retail, digital download, online platforms, and cloud streaming services. The company was founded by Ryan A. Brant in 1993 and is headquartered in New York, NY.

Take-Two Interactive Software, Inc.

Take-Two is drawing attention ahead of its earnings report and the scheduled GTA VI launch, with traders focused on preorder demand, managements outlook and the games potential for ongoing online revenue. Many expect the blockbuster to drive growth, while others argue its success is already priced in and the shares may need concrete sales results to move higher.

Firefly Aerospace, Inc. engages in the design and manufacture of space launch vehicles. The company was founded by Thomas E. Markusic, Mark Watt, and Max Polyakov in January 2017 and is headquartered in Leander, TX.

Firefly Aerospace Inc.

Fireflys engine, technology-licensing and engineering agreement with AST SpaceMobile for its planned Blacklift rocket, alongside NASAs CLPS 2 selection, is driving attention. Traders see the deal as validation and a boost to Fireflys backlog, while debating execution, the stock component of the agreement and funding risks ahead of earnings.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

CAPR is drawing attention ahead of the FDAs decision on deramiocel for Duchenne muscular dystrophy, with traders focused on whether the amended applications HOPE-3 upper-limb data will support approval; the trial investigators support letter is a bullish talking point, while the earlier advisory-panel vote concerned the cardiac indication. Sentiment is largely optimistic, with calls and short-squeeze potential frequently discussed, but traders also acknowledge the binary risk of a rejection or another delay.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMDs sharp rebound is being linked to Oppenheimers upgrade and Google Clouds use of AMD EPYC processors in its AI infrastructure, while traders also see Nvidias CEO investigation as a reason for money to rotate toward AMD. Bulls view the companys data-center momentum and rival-related headlines as supportive, while skeptics warn the move may be a volatile bounce after the recent semiconductor selloff.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerrys QNX and Valeo collaboration on a production-ready smart-camera platform, with design wins at multiple Chinese automakers, is driving attention. Many traders view it as evidence of expanding QNX adoption in automotive and a growth catalyst, while skeptics question how quickly wins will translate into meaningful revenue.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

IRTC Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into iRhythm Technologies, Inc. (IRTC)

IRTC Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into iRhythm Technologies, Inc. (IRTC) IRTC Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into iRhythm Technologies, Inc. (IRTC)PR NewswireNEW YORK, Nov. 6, 2026 A revenue shortfall...

iRhythm Holdings, Inc. (IRTC) Q3 Earnings Surpass Estimates

IRHYTHM HLDGS (IRTC) delivered earnings and revenue surprises of +4,000.00% and -0.31%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

iRhythm Holdings, Inc. (IRTC) Earnings Expected to Grow: Should You Buy?

IRHYTHM HLDGS (IRTC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Here's How Tempus AI Demonstrates Improving Operating Leverage

TEM shows improving operating leverage as Q2 revenues jump 22%, adjusted EBITDA turns positive and lower interest costs support its free cash flow goal.

Did iRhythm Technologies, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Did iRhythm Technologies, Inc. Insiders Breach their Fiduciary Duties to Shareholders? Did iRhythm Technologies, Inc. Insiders Breach their Fiduciary Duties to Shareholders?PR NewswireNEW YORK, Oct. 13, 2026Shareholders are encouraged to contact the firm to discuss their rights and options at no...

Should You Buy, Hold or Sell Tempus AI Stock Amid AI Boom?

TEM's strong data licensing growth, AI-driven innovations and rising shares favor holding the stock, but premium valuation and reimbursement risks warrant caution.

Here's How Tempus AI is Capitalizing on AI-ECG Market Growth

TEM is expanding its cardiovascular portfolio with FDA-cleared AI-ECG tools targeting complex cardiac conditions.

Butterfly Network (BFLY) Surges 22.0%: Is This an Indication of Further Gains?

Butterfly Network (BFLY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Here's Why You Should Retain IRTC Stock in Your Portfolio for Now

iRhythm's Q2 momentum, AI-driven predictive care and deeper EHR integration support growth, though reimbursement pressures remain.

Should Investors Buy IRTC as Growth Improves but Risks Stay Elevated?

iRhythm's Q2 revenue growth, margin expansion and record free cash flow strengthen its case, but reimbursement and regulatory risks remain elevated.

• Reported GAAP EPS of $0.82 up 1466.67% YoY
• Reported revenue of $221.59M up 14.88% YoY
• iRhythm increased fiscal year 2026 revenue guidance to $890M to $895M and adjusted EBITDA margin guidance to 15.5% to 16.0%, inclusive of VitalConnect and approximately $16M of expected VitalConnect revenue contribution.

iRhythm's GAAP net loss increased, operating expenses were higher alongside $49.8M of litigation settlements, and iRhythm identified intense competition in its markets as a risk to outcomes.

iRhythm reported Q3 revenue growth and gross-margin expansion, higher adjusted EBITDA, and completed VitalConnect's acquisition, adding an FDA-cleared mobile cardiac telemetry offering to its cardiac monitoring portfolio.

iRhythm Holdings, Inc. is a digital healthcare company, which engages in the provision of design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services. It also provides solutions that detect, predict, and prevent disease. The company was founded by Uday N. Kumar in September 2006 and is headquartered in San Francisco, CA.

iRhythm Holdings Inc.

Wells Fargo Upgrades iRhythm Technologies Stock, Raises Price Target To $130: Retail’s Thrilled

Equity

Bullish Sentiment

Shares of iRhythm Technologies, Inc. (IRTC) traded 21% higher on Friday afternoon after Wells Fargo upgraded the stock to ‘Overweight’ from ‘Equal Weight’, a day after it provided full-year guidance that exceeded Wall Street expectations.Wells Fargo also raised its price target on the stock to $130 from $104, as per TheFly. The new price target implies a 19.7% upside to IRTC’s closing price on Thursday.Wells Fargo believes that strong volume growth for iRhythm’s Zio AT device and good progress with value-based care accounts, among other factors, support the upside to iRhythm's guidance in 2025. iRhythm’s Zio AT device enables mobile cardiac telemetry (MCT) monitoring service.Baird also raised its price target on iRhythm to $150 from $133 while keeping an ‘Outperform’ rating on the shares.iRhythm Technologies on Thursday <a target="_blank" rel="noopener noreferrer nofollow" href="https://investors.irhythmtech.com/news/news-details/2025/iRhythm-Technologies-Announces-First-Quarter-2025-Financial-Results/default.aspx">reported</a> revenue of $158.7 million, a 20.3% increase compared to the first quarter of 2024. This increase was driven by momentum from innovative value-based care accounts, demand from Zio AT in the United States, and record demand in the United Kingdom.Adjusted loss per share came in at $0.95, compared to a loss of $1.23 per share recorded in the same period in 2024.iRhythm now expects revenue for 2025 to be between $690 million and $700 million, above an analyst estimate of $686.79 million, per Finchat data. The company also expects adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) margin for 2025 to range from approximately 7.5% to 8.5% of revenues.On Stocktwits, retail sentiment around IRTC jumped from ‘bearish’ to ‘extremely bullish’ territory over the past 24 hours while message volume rose from ‘low’ to ‘extremely high’ levels.<figure class="image"><img style="aspect-ratio:628/63;" src="https://news.stocktwits-cdn.com/Screenshot_2025_05_02_at_12_41_33_PM_png_372447f6d0.webp" alt="IRTC's Sentiment Meter and Message Volume as of 12:40 p.m. ET on May 2, 2025 | Source: Stocktwits" width="628" height="63"><figcaption>IRTC's Sentiment Meter and Message Volume as of 12:40 p.m. ET on May 2, 2025 | Source: Stocktwits</figcaption></figure> <a href="https://stocktwits.com/symbol/IRTC">IRTC stock</a> is up by about 47% this year and 18% over the past 12 months.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/gm-to-cut-shift-at-canada-oshawa-assembly-plant/chLUKbuRb0H">GM To Reduce Shifts At Canada’s Oshawa Assembly Plant Citing Evolving Trade Environment: Retail Stays Extremely Bullish</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

The firm’s new target on iRhythm implies a 19.7% upside to Thursday’s closing price.

iRhythm Technologies Inc

Vanguard Small Cap ETF

Vanguard Total Stock Market ETF

Buying the dip

Selling or trimming

Holding

Waiting for the investigation results to decide

Nvidia ($NVDA) is down about 4% after its board opened an investigation into CEO Jensen Huang. What are you doing with the stock?

Stocktwits

) is down about 4% after its board opened an investigation into CEO Jensen Huang. What are you doing with the stock?

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '26	$0.16	--	--	N/A
Q3 '26	$0.02	-$0.90	-5923.36%	MISSED
Q2 '26	-$0.04	-$0.01	75.00%	BEAT
Q1 '26	-$0.66	-$0.43	35.28%	BEAT
Q4 '25	$0.01	$0.17	1433.33%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

IRTC Earnings

Latest Earnings Results: Q3 '26

Historical Earnings